Organization (Industry)
Nihon Kohden (Japan)
ClinicalTrials.gov lists Nihon Kohden (Japan) as lead sponsor of 16 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Nihon Kohden Corporation, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Nihon Kohden (Japan): 16 lead-sponsored trials and 1 legal-entity registration.
Disease areas (9)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Hypoxia | 10 |
| Heart Failure | 3 |
| Chest Pain | 1 |
| Hypotension | 1 |
| Myocardial Infarction | 1 |
Showing 5 of 9 disease areas.
Trials by start year as sponsor or collaborator (11)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 2 |
| 2024 | 1 |
| 2023 | 4 |
| 2022 | 2 |
| 2021 | 5 |
| 2020 | 2 |
| 2019 | 2 |
| 2018 | 1 |
| 2015 | 1 |
Showing 10 of 11 years.
Recruitment duration, a model prediction: none of the 16 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 45% hit target (n=11) | 78% on time (n=9) |
Journals published in (17)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| The New England journal of medicine | 4 |
| American journal of respiratory and critical care medicine | 3 |
| JAMA | 3 |
| Journal of clinical monitoring and computing | 3 |
| Acta anaesthesiologica Scandinavica | 2 |
Showing 5 of 17 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 567 | 116 | 2025-12-30 |
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| NAI | 1 |
FDA import refusals (1)
| Refused import lines | Latest refusal |
|---|---|
| 5 | 2007-05-16 |
Manufacturing and distribution sites (1)
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| NIHON KOHDEN CORP. | SHINJUKU-KU T?ky?, JP | FDA |
Organization relationships (1)
| Related organization | Relationship | Evidence |
|---|---|---|
| University Health Network, Toronto | Co sponsors trial with | 1 |
Latest dated events (595)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-04-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12-30 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-12-30 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-12-23 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-12-09 | Patent granted | Granted US patents (PatentsView / USPTO) |
Showing 5 of 595 events.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda recalls, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.